Latest News

With no single fresh headline moving UiPath (PATH) today, the recent share performance stands out, including a 20% decline over the past month and negative total returns over the past year and the past 3 months. See our latest analysis for UiPath. At a share price of $13.00, UiPath’s recent 7 day share price return of 3.67% contrasts with a 30 day share price decline of 20.34% and a 1 year total shareholder return of 8.64% in the red. This points to fading momentum as investors reassess...

Ero Copper (TSX:ERO) is back in focus after issuing 2026 production guidance alongside its fourth quarter and full year 2025 operating results, giving investors fresh data on copper and gold output. See our latest analysis for Ero Copper. The latest guidance appears to have come against a backdrop of strong momentum, with a 90 day share price return of 38.04% and a 1 year total shareholder return of 116.65%. However, the 7 day share price return of negative 7.85% suggests some recent cooling...

Revvity (NYSE:RVTY) introduced several new discovery and automation platforms at SLAS2026. The company showcased the Opera Phenix OptIQ high content screening system, EnVision Nexus One plate reader, and AssayMate workstation. Revvity also highlighted collaborations around automated next generation sequencing workflows at the event. Revvity, which focuses on life science tools and diagnostics, is pushing deeper into high throughput drug discovery and lab automation with these SLAS2026...

If you are wondering whether Takeda Pharmaceutical's share price still offers value after its recent performance, this article will walk through what the current market price might be implying. The stock last closed at ¥5,565, with returns of 2.7% over 7 days, 9.5% over 30 days, 13.2% year to date, 41.7% over 1 year and 50.5% over 3 years. These figures may catch the eye of investors thinking about growth potential or shifts in risk perception. Recent news flow around Takeda Pharmaceutical...

Fiserv (NasdaqGS:FISV) is undergoing a reset under CEO Mike Lyons, centered on the "One Fiserv" plan to unify operations and simplify the business. The company has made leadership and board changes aimed at improving oversight, technology focus, and execution. Fiserv is also facing lawsuits that claim it previously overstated growth metrics, raising questions about past disclosures and investor communications. Fiserv sits at the crossroads of payments, banking technology, and merchant...

In February 2026, CMS Energy’s Board of Directors raised the quarterly common stock dividend to US$0.57 per share from US$0.5425, alongside reporting higher fourth-quarter and full-year 2025 sales, net income, and diluted earnings per share compared with the prior year. The combination of increased earnings and a higher dividend highlights CMS Energy’s emphasis on balancing business investment with ongoing cash returns to shareholders. Next, we’ll examine how CMS Energy’s earnings growth,...

McDonald's (NYSE:MCD) has appointed Ford CEO James D. Farley, Jr. to its Board of Directors. McDonald’s Malaysia plans to invest in opening 100 new outlets and upgrading digital platforms over the next five years. For readers tracking large consumer brands, McDonald's sits at the intersection of quick-service dining, global franchising, and increasingly, digital ordering and delivery. The addition of a leader from the auto sector brings experience from another global, operationally complex...

In early February 2026, Startale Group and SBI Holdings launched Strium, a blockchain-based exchange infrastructure designed for 24/7 trading and settlement of tokenized equities and real-world asset-linked instruments across spot and derivatives markets in Asia, while keeping issuance and custody separate for compatibility with existing financial systems. A day earlier, SBI Holdings reported that for the nine months ended December 31, 2025, sales rose to ¥1.49 trillions and net income to...

In early February 2026, a California federal jury found Medtronic liable for anticompetitive conduct in the advanced bipolar surgical devices market and ordered the company to pay more than US$381 million in damages to rival Applied Medical under U.S. and California antitrust laws. Beyond the large financial penalty, the verdict targets Medtronic’s contracting practices with hospitals and group purchasing organizations, potentially reshaping how its surgical devices compete for...

In early February 2026, Amcor reported second-quarter sales of US$5,449 million and net income of US$177 million, alongside a higher quarterly cash dividend of US$0.65 per share (A$0.93 per CDI) payable on March 17, 2026. At the same time, Amcor completed a review of portfolio alternatives covering businesses with about US$2.50 billion in sales, introducing execution and outcome risks that may affect how investors assess its future capital allocation and cash generation. We’ll now examine...

NetScout Systems (NTCT) has drawn investor attention after its latest quarterly update, which showed year over year net income and earnings per share growth, alongside raised earnings guidance for fiscal 2026 and improving analyst sentiment. See our latest analysis for NetScout Systems. Following the earnings beat and higher fiscal 2026 guidance, NetScout Systems' recent 30 day share price return of 1.97% contrasts with a softer 90 day share price return of 2.70%. At the same time, the 1 year...

Entegris: recent performance snapshot Entegris (ENTG) has been drawing attention after a strong run recently, with the stock showing positive returns over the past week, month and past 3 months, and a last close of $122.39. See our latest analysis for Entegris. The recent move to a share price of $122.39 sits within a strong run, with a 30-day share price return of 18.84% and a 90-day share price return of 45.63%, while the 1-year total shareholder return of 16.24% points to momentum that has...

Renewed interest in Catalyst Pharmaceuticals stock Renewed interest in Catalyst Pharmaceuticals (CPRX) stock has been driven by a mix of fundamental and technical factors, including recent revenue and earnings growth, high profitability, a debt free balance sheet, and a fresh Pocket Pivot signal. See our latest analysis for Catalyst Pharmaceuticals. At a share price of $24.45, Catalyst Pharmaceuticals has seen a 7.61% 1 month share price return and a 5.62% year to date share price return,...

nVent Electric (NYSE:NVT) is emphasizing acquisitions to support infrastructure build outs linked to AI driven data center demand. Management is highlighting deals as a key tool to expand the company’s presence in electrical connection and protection solutions. The acquisition focus is being framed as a way to complement existing operations and widen exposure to high growth infrastructure projects. nVent Electric focuses on electrical connection and protection products that sit behind...

If you are wondering whether Concentrix at around US$39.04 is a bargain or a value trap, this article will walk through what the current price might be telling you about the stock. The share price has moved 4.6% over the last 7 days, while returns sit at an 11.4% decline over 30 days, a 5.3% decline year to date, a 16.1% decline over 1 year, a 71.2% decline over 3 years, and a 62.0% decline over 5 years, which may change how investors think about its risk and potential. Recent coverage...

Recent commentary on Quebecor (TSX:QBR.A) has focused on its very large dividend expansion since 2016, supported by higher operating cash flow and a lower payout ratio, along with ongoing share buybacks. See our latest analysis for Quebecor. Despite a softer patch recently, with a 7 day share price return of 2.46% and year to date share price return of 3.89%, Quebecor’s longer run picture looks different. The 1 year total shareholder return of 57.18% and 5 year total shareholder return of...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

FactSet Research Systems (NYSE:FDS) has partnered with Kepler Cheuvreux to deliver expanded European equity research to clients across the EMEA region using AI tools. The company has also launched an AI Doc Ingest beta tool within its Cobalt platform, aimed at helping private capital managers automate and structure document data. FactSet Research Systems enters this news with its shares at $203.22 and a value score of 5. The stock has seen sizeable declines, with returns of 18.3% over the...

State Street Corporation recently signed a support agreement with the Abu Dhabi Investment Office to build a new operating center in Al Ain, expanding its Middle East footprint and creating more than 300 financial services roles over four years while deepening ties to the Abu Dhabi Global Market ecosystem. By pairing local hiring and university partnerships with an upgraded ADGM licence, State Street is weaving itself into Abu Dhabi’s push for a knowledge-based, globally competitive...

Wells Fargo (NYSE:WFC) is under scrutiny over check fraud cases involving elderly and vulnerable customers. Some affected customers were initially denied reimbursement because claims were submitted after internal reporting deadlines. At least one high profile case was later reimbursed after gaining public attention, raising questions about the bank's fraud policies. The situation is drawing attention to consumer protections and the strength of fraud safeguards at large US banks. Wells Fargo...

Concerns about advanced AI agents potentially replacing traditional software tasks recently pressured cloud security names, with Zscaler (ZS) caught in the sector sell-off despite its focus on zero trust security and AI focused product development. See our latest analysis for Zscaler. Against that backdrop, Zscaler’s share price has retreated. It has a 7 day share price return of 9.5% and a 30 day share price return of 21.48%, while its 1 year total shareholder return of 18.67% sits against a...

Sun Country Airlines Holdings, Inc. has reported its fourth-quarter 2025 results, with revenue rising to US$280.96 million while net income eased to US$8.15 million, and full-year 2025 revenue increasing to US$1.13 billion with net income essentially unchanged at US$52.81 million versus 2024. An interesting aspect of this update is that higher quarterly and full-year revenues did not translate into higher profits, leading to slightly lower quarterly earnings per share compared with the prior...

HKT Trust and HKT (SEHK:6823) has reported its FY 2025 second half with total revenue of HK$19.2b and basic EPS of HK$0.42, alongside trailing twelve month revenue of HK$36.6b and EPS of HK$0.70. The group has seen revenue progress from HK$18.1b in 2H 2024 to HK$19.2b in 2H 2025, while basic EPS moved from HK$0.41 to HK$0.42 over the same periods, setting the scene for investors to weigh modest earnings momentum against steady top line expansion. With a trailing net income of HK$5.3b and a...

Why Simpson Manufacturing’s latest results matter for shareholders Simpson Manufacturing (SSD) just reported its fourth quarter and full year 2025 results, with higher sales and net income year over year, reaffirmed its regular dividend, and shared a supportive margin outlook for 2026. See our latest analysis for Simpson Manufacturing. The recent results and dividend affirmation seem to have fed into a strong run in the share price, with Simpson Manufacturing’s 30 day share price return of...